These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 14758013)

  • 21. CCR5 antagonists as anti-HIV-1 agents. 1. Synthesis and biological evaluation of 5-oxopyrrolidine-3-carboxamide derivatives.
    Imamura S; Ishihara Y; Hattori T; Kurasawa O; Matsushita Y; Sugihara Y; Kanzaki N; Iizawa Y; Baba M; Hashiguchi S
    Chem Pharm Bull (Tokyo); 2004 Jan; 52(1):63-73. PubMed ID: 14709870
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Noncompetitive NMDA antagonists: a novel synthesis of 1-phenyltetrahydro-3-benzazepines.
    Wünsch B; Nerdinger S; Bauschke G; Höfner G
    Arch Pharm (Weinheim); 1997 Jul; 330(7):211-4. PubMed ID: 9311300
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and structure-activity relationships of amide derivatives of (4,4-difluoro-1,2,3,4-tetrahydro-5H-1-benzazepin-5-ylidene)acetic acid as selective arginine vasopressin V2 receptor agonists.
    Tsukamoto I; Koshio H; Kuramochi T; Saitoh C; Yanai-Inamura H; Kitada-Nozawa C; Yamamoto E; Yatsu T; Shimada Y; Sakamoto S; Tsukamoto S
    Bioorg Med Chem; 2009 Apr; 17(8):3130-41. PubMed ID: 19321349
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and structure-activity relationships of a series of benzazepine derivatives as 5-HT2C receptor agonists.
    Shimada I; Maeno K; Kondoh Y; Kaku H; Sugasawa K; Kimura Y; Hatanaka K; Naitou Y; Wanibuchi F; Sakamoto S; Tsukamoto S
    Bioorg Med Chem; 2008 Mar; 16(6):3309-20. PubMed ID: 18083579
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CCR5 antagonists as anti-HIV-1 agents. Part 3: Synthesis and biological evaluation of piperidine-4-carboxamide derivatives.
    Imamura S; Nishikawa Y; Ichikawa T; Hattori T; Matsushita Y; Hashiguchi S; Kanzaki N; Iizawa Y; Baba M; Sugihara Y
    Bioorg Med Chem; 2005 Jan; 13(2):397-416. PubMed ID: 15598561
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 1,3-Disubstituted benzazepines as novel, potent, selective neuropeptide Y Y1 receptor antagonists.
    Murakami Y; Hara H; Okada T; Hashizume H; Kii M; Ishihara Y; Ishikawa M; Shimamura M; Mihara S; Kato G; Hanasaki K; Hagishita S; Fujimoto M
    J Med Chem; 1999 Jul; 42(14):2621-32. PubMed ID: 10411482
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phenolic derivatives from Wigandia urens with weak activity against the chemokine receptor CCR5.
    Cao S; Rossant C; Ng S; Buss AD; Butler MS
    Phytochemistry; 2003 Nov; 64(5):987-90. PubMed ID: 14561515
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An efficient preparation of N-alkyl-2-benzazepine derivatives and investigation of their biological activity.
    Kamimura A; So M; Kuratani T; Matsuura K; Inui M
    Bioorg Med Chem Lett; 2009 Jun; 19(12):3193-5. PubMed ID: 19442522
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Discovery and characterization of novel, potent, non-peptide parathyroid hormone-1 receptor antagonists.
    McDonald IM; Austin C; Buck IM; Dunstone DJ; Gaffen J; Griffin E; Harper EA; Hull RA; Kalindjian SB; Linney ID; Low CM; Patel D; Pether MJ; Raynor M; Roberts SP; Shaxted ME; Spencer J; Steel KI; Sykes DA; Wright PT; Xun W
    J Med Chem; 2007 Oct; 50(20):4789-92. PubMed ID: 17850061
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [2-(4-Phenyl-4-piperidinyl)ethyl]amine based CCR5 antagonists: derivatizations at the N-terminal of the piperidine ring.
    Duan M; Aquino C; Ferris R; Kazmierski WM; Kenakin T; Koble C; Wheelan P; Watson C; Youngman M
    Bioorg Med Chem Lett; 2009 Mar; 19(6):1610-3. PubMed ID: 19233649
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and anti-microbial activity of benzo-condensed heterocyclic derivatives.
    Bonsignore L; Loy G; Secci D; De Logu A; Palmieri G
    Farmaco; 1990 Nov; 45(11):1245-50. PubMed ID: 2088367
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
    Tewes B; Frehland B; Schepmann D; Schmidtke KU; Winckler T; Wünsch B
    Bioorg Med Chem; 2010 Nov; 18(22):8005-15. PubMed ID: 20965739
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and anthelmintic activity of a series of pyrazino[2,1-a][2]benzazepine derivatives.
    Brewer MD; Burgess MN; Dorgan RJ; Elliott RL; Mamalis P; Manger BR; Webster RA
    J Med Chem; 1989 Sep; 32(9):2058-62. PubMed ID: 2769679
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis of racemic 6,7,8,9-tetrahydro-3-hydroxy-1H-1-benzazepine-2,5-diones as antagonists of N-methyl-d-aspartate (NMDA) and alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) receptors.
    Guzikowski AP; Whittemore ER; Woodward RM; Weber E; Keana JF
    J Med Chem; 1997 Jul; 40(15):2424-9. PubMed ID: 9240357
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular interactions of CCR5 with major classes of small-molecule anti-HIV CCR5 antagonists.
    Kondru R; Zhang J; Ji C; Mirzadegan T; Rotstein D; Sankuratri S; Dioszegi M
    Mol Pharmacol; 2008 Mar; 73(3):789-800. PubMed ID: 18096812
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analogs of 3-hydroxy-1H-1-benzazepine-2,5-dione: structure-activity relationship at N-methyl-D-aspartate receptor glycine sites.
    Guzikowski AP; Cai SX; Espitia SA; Hawkinson JE; Huettner JE; Nogales DF; Tran M; Woodward RM; Weber E; Keana JF
    J Med Chem; 1996 Nov; 39(23):4643-53. PubMed ID: 8917653
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pyrrolo[1,3]benzothiazepine-based serotonin and dopamine receptor antagonists. Molecular modeling, further structure-activity relationship studies, and identification of novel atypical antipsychotic agents.
    Campiani G; Butini S; Fattorusso C; Catalanotti B; Gemma S; Nacci V; Morelli E; Cagnotto A; Mereghetti I; Mennini T; Carli M; Minetti P; Di Cesare MA; Mastroianni D; Scafetta N; Galletti B; Stasi MA; Castorina M; Pacifici L; Vertechy M; Di Serio S; Ghirardi O; Tinti O; Carminati P
    J Med Chem; 2004 Jan; 47(1):143-57. PubMed ID: 14695828
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discovery of potent, nonsystemic apical sodium-codependent bile acid transporter inhibitors (Part 2).
    Huang HC; Tremont SJ; Lee LF; Keller BT; Carpenter AJ; Wang CC; Banerjee SC; Both SR; Fletcher T; Garland DJ; Huang W; Jones C; Koeller KJ; Kolodziej SA; Li J; Manning RE; Mahoney MW; Miller RE; Mischke DA; Rath NP; Reinhard EJ; Tollefson MB; Vernier WF; Wagner GM; Rapp SR; Beaudry J; Glenn K; Regina K; Schuh JR; Smith ME; Trivedi JS; Reitz DB
    J Med Chem; 2005 Sep; 48(18):5853-68. PubMed ID: 16134951
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis, σ receptor affinity, and pharmacological evaluation of 5-phenylsulfanyl- and 5-benzyl-substituted tetrahydro-2-benzazepines.
    Hasebein P; Frehland B; Schepmann D; Wünsch B
    ChemMedChem; 2014 Aug; 9(8):1697-703. PubMed ID: 24895069
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 2-benzazepines. 6. Synthesis and pharmacological properties of the metabolites of 9-chloro-7-(2-chlorophenyl)-5H-pyrimido[5,4-d] [2]benzazepine.
    Trybulski EJ; Fryer RI; Reeder E; Walser A; Blount J
    J Med Chem; 1983 Nov; 26(11):1596-601. PubMed ID: 6138437
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.